Purpose: The study aimed to analyze the clinical characteristics, laboratory test results, neuroimaging findings, and outcomes in patients diagnosed with subacute combined degeneration (SCD). Materials and Methods: A total of 68 patients with SCD who had been appropriately treated for no less than 6 months were included in our study. Histories, results of routine blood tests, biochemical indices, serum vitamin B12 levels, and spinal magnetic resonance imaging (MRI) findings from the patients were studied and analyzed. Clinical signs and symptoms, graded using a functional disability rating scale, were scored at the time of admission and 3 and 6 months after admission. Results: Limb numbness, limb weakness, and gait disturbances were the most common symptoms in patients with SCD. All patients showed clinical improvement to different degrees at the follow-up visits after vitamin B12 treatment. No differences in rating score were found in patients grouped by sex, hemoglobin level, serum vitamin B12, or MRI manifestations at the time of admission or at the follow-up visits. Younger patients and those with shorter disease courses had better rating scores at the short-term follow-up visits. Conclusion: Anemia, low levels of serum vitamin B12, and MRI abnormalities in the spinal cord are not expected to be associated with worse clinical manifestations. The age of onset and course of disease are important in evaluating the short-term prognosis of patients with SCD.

Keywords:
Subacute combined degeneration, Magnetic resonance imaging, Vitamin B12, Spinal cord
1.
Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al: Cobalamin deficiency: clinical picture and radiological findings. Nutrients 2013; 5: 4521–4539.
2.
Li J, Ren M, Dong A, Wu Y, Han N, Deng B, Bi X: A retrospective study of 23 cases with subacute combined degeneration. Int J Neurosci 2016; 126: 872–877.
3.
Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J: Neurologic aspects of cobalamin deficiency. Medicine (Baitimore) 1991; 70: 229–245.
4.
Narra R, Mandapalli A, Jukuri N, Guddanti P: “Inverted V sign” in sub-acute combined degeneration of cord. J Clin Diagn Res 2015; 9:TJ01.
5.
Grasbeck R: Imerslund-Gräsbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). Orphanet J Rare Dis 2006; 1: 17.
6.
Massey TH, Pickersgill TT, J Peall K: Nitrous oxide misuse and vitamin B12 deficiency. BMJ case rep 2016; 2016:pii:bcr2016215728.
7.
Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZM: Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med 2006; 21: 1063–1068.
8.
Kumar N, Gross JB Jr, Ahlskog JE: Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004; 63: 33–39.
9.
Turner MR, Talbot K: Functional vitamin B12 deficiency. Pract Neurol 2009; 9: 37–41.
10.
Kalita J, Chandra S, Bhoi SK, Agarwal R, Misra UK, Shankar SK, et al: Clinical, nerve conduction and nerve biopsy study in vitamin B12 deficiency neurological syndrome with a short-term follow-up. Nutr Neurosci 2014; 17: 156–163.
11.
Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lücking CH: Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998; 65: 822–827.
12.
Herrmann W, Obeid R: Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int 2008; 105: 680–685.
13.
Roessler FC, Wolff S: Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report. BMC Res Notes 2017; 10: 18.
14.
Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005; 3:CD004655.
15.
Hvas AM, Nexo E: Diagnosis and treatment of vitamin b12 deficiency–an update. Haematologica 2006; 91: 1506–1512.
16.
Bastrup-Madsen P, Helleberg-Rasmussen I, Nørregaard S, Halver B, Hansen T: Long term therapy of pernicious anaemia with the depot cobalamin preparation betolvex. Scand J Haematol 1983; 31: 57–62.
17.
Miscusi M, Testaverde L, Rago A, Raco A, Colonnese C: Subacute combined degeneration without nutritional anemia. J Clin Neurosci 2012; 19: 1744–1745.
18.
Dali-Youcef N, Andres E: An update on cobalamin deficiency in adults. QJM 2009; 102: 17–28.
19.
Jain KK, Malhotra HS, Garg RK, Gupta PK, Roy B, Gupta RK: Prevalence of MR imaging abnormalities in vitamin B12 deficiency patients presenting with clinical features of subacute combined degeneration of the spinal cord. J Neurol Sci 2014; 342: 162–166.
20.
Ravina B, Loevner LA, Bank W: MR findings in subacute combined degeneration of the spinal cord: a case of reversible cervical myelopathy. Am J Roentgenol 2000; 174: 863–865.
21.
Karantanas AH, Markonis A, Bisbiyiannis G: Subacute combined degeneration of the spinal cord with involvement of the anterior columns: a new MRI finding. Neuroradiology 2000; 42: 115–117.
22.
Xiao CP, Ren CP, Cheng JL, Zhang Y, Li Y, Li BB, et al: Conventional MRI for diagnosis of subacute combined degeneration (SCD) of the spinal cord due to vitamin B-12 deficiency. Asia Pac J Clin Nutr 2016; 25: 34–38.
23.
Gupta PK, Gupta RK, Garg RK, Rai Y, Roy B, Pandey CM, et al: DTI correlates of cognition in conventional MRI of normal-appearing brain in patients with clinical features of subacute combined degeneration and biochemically proven vitamin B(12) deficiency. AJNR Am J Neuroradiol 2014; 35: 872–877.
24.
Murata S, Naritomi H, Sawada T: MRI in subacute combined degeneration. Neuroradiology 1994; 36: 408–409.
25.
Wong SH, Boggild M, Enevoldson TP, Fletcher NA: Myelopathy but normal MRI: Where next? Pract Neurol 2008; 8: 90–102.
26.
Maamar M, Mezalek ZT, Harmouche H, Adnaoui M, Aouni M, Maaouni A, et al: Contribution of spinal MRI for unsuspected cobalamin deficiency in isolated sub-acute combined degeneration. Eur J Intern Med 2008; 19: 143–145.
27.
Locatelli ER, Laureno R, Ballard P, Mark AS: MRI in vitamin b12 deficiency myelopathy. Can J Neurol Sci 1999; 26: 60–63.
28.
Berlit P, Ringelstein A, Liebig T: Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency. Neurology 2004; 63: 592.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.